Table 5.
Liver cancer stage according to serological results and liver ultrasonography, 2012–2015.
| Cancer stage (BCLC) | Total | |||||
|---|---|---|---|---|---|---|
| 0 or A | B | C | D | missing | ||
| HBsAg status at baseline | ||||||
| Negative | ||||||
| Cases of liver cancer (no.) | 3 | 2 | 5 | 3 | 1 | 14 |
| Deaths from liver cancer (no. %) | 1 (33.3) | 2 (100.0) | 5 (100.0) | 3 (100.0) | 0 (0.0) | 11 (84.6) |
| Positive | ||||||
| Cases of liver cancer (no.) | 10 | 13 | 14 | 4 | 2 | 43 |
| Deaths from liver cancer (no. %) | 2 (20.0) | 7 (53.8) | 11 (78.6) | 2 (50.0) | 0 (0.0) | 22 (51.2) |
| Among HBsAg-positive group only | ||||||
| AFP (baseline) | ||||||
| Negative | ||||||
| Cases of liver cancer (no.) | 7 | 11 | 11 | 4 | 2 | 35 |
| Deaths from liver cancer (no. %) | 1 (14.3) | 6 (54.5) | 8 (72.7) | 2 (50.0) | 0 (0.0) | 17 (48.6) |
| Positive | ||||||
| Cases of liver cancer (no.) | 3 | 2 | 3 | 0 | 0 | 8 |
| Deaths from liver cancer (no. %) | 1 (33.3) | 1 (50.0) | 3 (100.0) | 0 (0.0) | 0 (0.0) | 5 (62.5) |
| AFP (baseline + follow-up) | ||||||
| Negative | ||||||
| Cases of liver cancer (no.) | 6 | 8 | 8 | 2 | 2 | 26 |
| Deaths from liver cancer (no. %) | 1 (16.7) | 3 (37.5) | 6 (75.0) | 1 (50.0) | 0 (0.0) | 11 (42.3) |
| Positive | ||||||
| Cases of liver cancer (no.) | 4 | 5 | 6 | 2 | 0 | 17 |
| Deaths from liver cancer (no. %) | 1 (25.0) | 4 (80.0) | 5 (83.3) | 1 (50.0) | 0 (0.0) | 11 (64.7) |
| Ultrasonography (baseline) | ||||||
| Normal | ||||||
| Cases of liver cancer (no.) | 1 | 0 | 4 | 0 | 1 | 6 |
| Deaths from liver cancer (no. %) | 0 (0.0) | 0 (0.0) | 3 (75.0) | 0 (0.0) | 0 (0.0) | 3 (50.0) |
| Abnormal | ||||||
| Cases of liver cancer (no.) | 3 | 6 | 8 | 2 | 0 | 19 |
| Deaths from liver cancer (no. %) | 0 (0.0) | 3 (50.0) | 7 (87.5) | 1 (50.0) | 0 (0.0) | 11 (57.9) |
| Missing | ||||||
| Cases of liver cancer (no.) | 6 | 7 | 2 | 2 | 1 | 18 |
| Deaths from liver cancer (no. %) | 2 (33.3) | 4 (57.1) | 1 (50.0) | 1 (50.0) | 0 (0.0) | 8 (44.4) |
| Ultrasonography (baseline + follow-up) | ||||||
| Normal | ||||||
| Cases of liver cancer (no.) | 0 | 0 | 0 | 0 | 0 | 0 |
| Deaths from liver cancer (no. %) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Abnormal (any) | ||||||
| Cases of liver cancer (no.) | 6 | 9 | 12 | 3 | 1 | 31 |
| Deaths from liver cancer (no. %) | 0 (0.0) | 4 (44.4) | 9 (75.0) | 1 (33.3) | 0 (0.0) | 14 (45.2) |
| Missing (all) | ||||||
| Cases of liver cancer (no.) | 4 | 4 | 2 | 1 | 1 | 12 |
| Deaths from liver cancer (no. %) | 2 (50.0) | 3 (75.0) | 2 (100.0) | 1 (100.0) | 0 (0.0) | 8 (66.7) |
Abbreviations: AFP, alpha-fetoprotein; BCLC, Barcelona Clinic Liver Cancer; HBsAg, Hepatitis B virus surface antigen.